Evidence map›Paper›PMID 33821192›Full record

ArticleClinical case reports2021

Combination of convalescent plasma therapy and repurposed drugs to treat severe COVID-19 patient with multimorbidity.

Santa Kumar Das, Kamal Ranabhat, Suraj Bhattarai, Khem Bahadur Karki, Pradip Gyanwali, Hem Raj Paneru, Bipin Nepal, Shyam Prakash Dumre, Subhash Prasad Acharya

Abstract readCase Reports
In one paragraph

Article in Clinical case reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Santa Kumar DasInstitute of Medicine Tribhuvan University Teaching Hospital Kathmandu Nepal.
Kamal RanabhatInstitute of Medicine Tribhuvan University Teaching Hospital Kathmandu Nepal.
Suraj BhattaraiGlobal Institute for Interdisciplinary Studies Kathmandu Nepal.ORCID https://orcid.org/0000-0001-6843-6677
Khem Bahadur KarkiInstitute of Medicine Tribhuvan University Teaching Hospital Kathmandu Nepal.
Pradip GyanwaliInstitute of Medicine Tribhuvan University Teaching Hospital Kathmandu Nepal.
Hem Raj PaneruInstitute of Medicine Tribhuvan University Teaching Hospital Kathmandu Nepal.
Bipin NepalGrande International Hospital Kathmandu Nepal.
Shyam Prakash DumreCentral Department of Microbiology Tribhuvan University Kathmandu Nepal.
Subhash Prasad AcharyaInstitute of Medicine Tribhuvan University Teaching Hospital Kathmandu Nepal.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Combination of convalescent plasma therapy and repurposed drugs such as dexamethasone and remdesivir could be beneficial for severe COVID-19 patients with obesity and chronic diseases such as diabetes and hypertension.

Indexed as

convalescent plasma therapyCOVID‐19 infectionmultimorbidityNepal

Identifiers

PMID33821192
PMCPMC8013972

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.